Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors.
Pérez-Lamas L, Luna A, Boque C, Xicoy B, Giraldo P, Pérez López R, Ruiz Nuño C, De Las Heras N, Mora Casterá E, López Marín J, Segura Díaz A, Gómez V, Vélez Tenza P, Sierra Pacho M, Vera Goñi JA, Moreno Vega M, Alvarez-Larrán A, Cortés M, Pérez Encinas M, Carrascosa Mastell P, Angona A, Rosell A, Lakhwani S, Colorado M, Ramila E, Cervero C, Cuevas B, Villalón Blanco L, de Paz R, Paz Coll A, Fernández MJ, Felipe Casado L, Alonso-Domínguez JM, Anguita Arance MM, Salamanca Cuenca A, Jiménez-Velasco A, Prendes SO, Santaliestra M, Lis Chulvi MJ, Hernández-Boluda JC, García-Gutiérrez V. Pérez-Lamas L, et al. Among authors: segura diaz a. Cancers (Basel). 2023 Feb 7;15(4):1045. doi: 10.3390/cancers15041045. Cancers (Basel). 2023. PMID: 36831388 Free PMC article.
Presence of Myeloid Mutations in Patients with Chronic Myeloid Leukemia Increases Risk of Cardiovascular Event on Tyrosine Kinase Inhibitor Treatment.
Stuckey R, Segura-Díaz A, Sáez Perdomo MN, Pérez Encinas MM, González San Miguel JD, Florido Y, Sánchez-Sosa S, López-Rodríguez JF, Bilbao-Sieyro C, Gómez-Casares MT; Spanish CML Group (GELMC). Stuckey R, et al. Among authors: segura diaz a. Cancers (Basel). 2023 Jun 28;15(13):3384. doi: 10.3390/cancers15133384. Cancers (Basel). 2023. PMID: 37444494 Free PMC article.
Thrombotic Risk Detection in Patients with Polycythemia Vera: The Predictive Role of DNMT3A/TET2/ASXL1 Mutations.
Segura-Díaz A, Stuckey R, Florido Y, González-Martín JM, López-Rodríguez JF, Sánchez-Sosa S, González-Pérez E, Sáez Perdomo MN, Perera MDM, de la Iglesia S, Molero-Labarta T, Gómez-Casares MT, Bilbao-Sieyro C. Segura-Díaz A, et al. Cancers (Basel). 2020 Apr 10;12(4):934. doi: 10.3390/cancers12040934. Cancers (Basel). 2020. PMID: 32290079 Free PMC article.
DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study.
Segura-Díaz A, Stuckey R, Florido Y, Sobas M, Álvarez-Larrán A, Ferrer-Marín F, Pérez-Encinas M, Carreño-Tarragona G, Fox ML, Tazón Vega B, Cuevas B, López Rodríguez JF, Sánchez-Farías N, González-Martín JM, Gómez-Casares MT, Bilbao-Sieyro C; Spanish MPN Group (GEMFIN). Segura-Díaz A, et al. Thromb Haemost. 2024 Jan 30. doi: 10.1055/a-2239-9265. Online ahead of print. Thromb Haemost. 2024. PMID: 38190984
The Cardiovascular Event Risk Associated with Tyrosine Kinase Inhibitors and the Lipid Profile in Patients with Chronic Myeloid Leukemia.
Saez Perdomo MN, Stuckey R, González-Pérez E, Sánchez-Sosa S, Estupiñan-Cabrera P, Lakhwani Lakhwani S, González San Miguel JD, Hernanz Soler N, Gordillo M, González Brito G, Tapia-Torres M, Ruano A, Segura-Díaz A, Luzardo H, Bilbao-Sieyro C, Gómez-Casares MT. Saez Perdomo MN, et al. Among authors: segura diaz a. Hematol Rep. 2024 Mar 12;16(1):140-150. doi: 10.3390/hematolrep16010015. Hematol Rep. 2024. PMID: 38534885 Free PMC article.